What’s new

What's new

• 09 Feb 2012 | Medical Device Alert: Reagents requiring manual handling for use in combination with Cobas c501/502 analyser manufactured by Hitachi (MDA/2012/004)
  

  This Medical Device Alert has been issued because the use of insufficient volumes of reagent may lead to a false negative result leading to patient harm.

• 09 Feb 2012 | Class 3 Drug Alert: Teva UK Limited - Alendronic Acid 10mg Tablets - EL(12)A/06
  

  During non-routine testing 10 months after manufacture, some samples were found to be marginally out of specification for assay. This finding is not expected to impact on patient safety at this stage but there are concerns about potential effects on potency of the batch during the remainder of the shelf-life.

• 08 Feb 2012 | Press release: Two men sentenced for illegal online sale of Prescription Only Medicines and Class C steroids
  

  Two men were sentenced yesterday at Chelmsford Crown Court for their involvement in the illegal online sale and supply of prescription-only medicines and numerous anabolic steroids.

• 08 Feb 2012 | Press release: MHRA welcomes a new Director of Medical Devices
  

  John Wilkinson OBE joins the Medicines and Healthcare products Regulatory Agency (MHRA) as Director of Medical Devices this week.

• 08 Feb 2012 | Press release: New appointments to the British Pharmacopoeia Commission
  

  The British Pharmacopoeia (BP) Commission and the Appointments Commission are pleased to announce the appointment of five new members to the BP Commission.

• 08 Feb 2012 | Five-day payment performance
  

  This page provides information on the five-day payment performance from April 2011.

• 07 Feb 2012 | Class 4 Drug Alert: Updated information for our alerts EL(11)A/32 of 21 December 2011 and EL(12)A/01 of 11 January 2012 - EL(12)A/05
  

  Following our alerts EL(11)A/32 issued on 21 December 2011 and EL(12)A/01 issued on 11 January 2012, B.Braun Medical Ltd  have advised us that they need to release additional batches of  the above NuTRIflex Lipid products which may contain particulates and should be subject to the same additional filtration process previously recommended during infusion.

• 06 Feb 2012 | Report on PIP implants issued by the Scientific Committee on Emerging and Newly Identified Health Risks of the European Commission
  

  A report on PIP implants has been issued by the Scientific Committee on Emerging and Newly Identified Health Risks of the European Commission, which states that there is insufficient evidence to warrant a conclusion that women with PIP silicone breast implants have a greater risk to their health than women with breast implants from other manufacturers.

• 06 Feb 2012 | Monthly list of MDAs 2012
  

  A month-by-month list of Medical Device Alerts that we have issued in 2012.

• 06 Feb 2012 | Public consultation (ARM 81): Request to reclassify Imodium Instants (loperamide hydrochloride) 12 tablet pack size from Pharmacy (P) to General Sales List (GSL)
  

  Consultation ARM 81 seeks your views on the reclassification of Imodium Instants (loperamide hydrochloride) 12 tablet pack size from Pharmacy (P) to General Sales List (GSL). Comments are invited by 5 March 2012.